Akamai EVP sells 5,000 shares under 10b5-1 plan

Akamai Technologies EVP – Global Sales Paul C. Joseph reported selling a total of 5,000 shares of Common Stock on March 16, 2026 in open-market transactions.

Accepted by SEC EDGAR 03/16/2026 - 04:27 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akamai Technologies EVP – Global Sales Paul C. Joseph reported selling a total of 5,000 shares of Common Stock on March 16, 2026 in open-market transactions. The sales occurred at weighted average prices of $105.8858, $106.7328, and $108.00 per share.

These transactions were executed under a Rule 10b5-1 trading plan adopted on March 17, 2025, indicating they were pre‑scheduled. After the sales, Joseph directly holds 34,533 shares, and an additional 165.196 shares are held indirectly through a 401(k) plan as of March 13, 2026.

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares

Net Sell 3 txns

Insider Joseph Paul C

Role EVP - Global Sales

Sold 5,000 shs ($531K)

Share of Position Sold 12.6%

Type	Security	Shares	Price	Value
Sale	Common Stock	2,967	$105.8858	$314K
Sale	Common Stock	1,950	$106.7328	$208K
Sale	Common Stock	83	$108.00	$9K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 34,533 shares (Direct); Common Stock — 165.196 shares (Indirect, By 401(k) Plan)

Holdings Before and After: Common Stock, 39,533 to 34,533 shares (Direct)

Other Insiders: 8 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

1. F1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2025.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.39 to $106.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.41 to $107.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. As of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Akamai (AKAM) report for EVP Paul C. Joseph?

Akamai reported that EVP – Global Sales Paul C. Joseph sold 5,000 shares of Common Stock. The open-market sales took place on March 16, 2026, at weighted average prices between roughly $105.39 and $108.00 per share, according to detailed price ranges disclosed.

Were the March 2026 Akamai (AKAM) insider sales by Paul C. Joseph pre-planned?

Yes, the filing states the sales were made under a Rule 10b5-1 trading plan. That plan was adopted on March 17, 2025, meaning the transactions were pre-scheduled rather than discretionary, which typically reduces the signaling value of their exact timing for investors.

How many Akamai (AKAM) shares does Paul C. Joseph hold after the reported sales?

After the March 16, 2026 transactions, Paul C. Joseph directly holds 34,533 Akamai shares. The filing also notes an additional 165.196 shares held indirectly through a 401(k) plan as of March 13, 2026, providing a view of his remaining equity stake.

What prices were received in the March 16, 2026 Akamai (AKAM) insider sales?

The reported weighted average sale prices were $105.8858, $106.7328, and $108.00 per share. Footnotes explain these are averages for multiple trades within ranges from $105.39 to $107.32, and more granular trade data is available upon request from the reporting person.

What role does Paul C. Joseph hold at Akamai (AKAM) in this Form 4 filing?

In this Form 4, Paul C. Joseph is identified as Akamai’s EVP – Global Sales. His reported transactions involve sales of the company’s Common Stock and reflect activity by a senior operating executive, not a director or 10% beneficial owner, according to the filing details.

Does the Akamai (AKAM) Form 4 show any remaining derivative positions for Paul C. Joseph?

No derivative positions are listed in the derivative section of this Form 4 for Paul C. Joseph. The derivativeSummary is empty, so only non-derivative Common Stock holdings and transactions are disclosed in this particular filing, without any options or other convertible securities shown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Joseph Paul C

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Global Sales

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		S(1)		2,967	D	$105.8858(2)	36,566	D
Common Stock	03/16/2026		S(1)		1,950	D	$106.7328(3)	34,616	D
Common Stock	03/16/2026		S(1)		83	D	$108	34,533	D
Common Stock								165.196(4)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.39 to $106.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.41 to $107.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. As of March 13, 2026.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.